Trans Genic Inc. (2342.T)
JPY 175.0
(-1.69%)
JPY 175.0
(-1.69%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.32 Billion JPY | -23.64% |
| 2022 | 1.73 Billion JPY | 61.51% |
| 2021 | 1.07 Billion JPY | -34.06% |
| 2020 | 1.63 Billion JPY | 53.79% |
| 2019 | 1.06 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.24 Billion JPY | -4.79% |
| 2023 Q1 | 1.56 Billion JPY | -9.8% |
| 2023 Q4 | 1.32 Billion JPY | -6.63% |
| 2023 Q3 | 1.42 Billion JPY | -2.44% |
| 2023 Q2 | 1.45 Billion JPY | -7.07% |
| 2023 FY | 1.32 Billion JPY | -23.64% |
| 2022 Q4 | 1.73 Billion JPY | -4.51% |
| 2022 FY | 1.73 Billion JPY | 61.51% |
| 2022 Q3 | 1.82 Billion JPY | 99.77% |
| 2022 Q2 | 911.1 Million JPY | 0.0% |
| 2021 FY | 1.07 Billion JPY | -34.06% |
| 2020 FY | 1.63 Billion JPY | 53.79% |
| 2019 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -73.014% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 33.646% |
| Linical Co., Ltd. | 1.49 Billion JPY | 11.525% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -169820.102% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 43.458% |
| AnGes, Inc. | 214.94 Million JPY | -517.391% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -1142.011% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 97.901% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -1469.371% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -19.673% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -4572.474% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | -51.562% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -3298.402% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 27.796% |
| PeptiDream Inc. | 19.63 Billion JPY | 93.241% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -723.759% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -234.276% |
| Healios K.K. | 450 Million JPY | -194.906% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -1616.986% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | -71.614% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | -68.411% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -170.087% |
| StemCell Institute Inc. | 6.67 Million JPY | -19778.31% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -823.183% |